News & Opinion

News

Quick Hits: Medication Recommended for Women at High Breast Cancer Risk, FDA Committee Supports Gout Drug & More

January 17, 2019
Quick Hits: Medication Recommended for Women at High Breast Cancer Risk, FDA Committee Supports Gout Drug & More

Women who are at high risk of developing breast cancer and who face a low risk of suffering adverse events should be given a drug such as tamoxifen, according to a recently released recommendation. The US Preventive Services Task Force (USPSTF) says that women at low breast cancer risk should Continue Reading →

No Increased Adverse Event Risk With Opioid, Alcohol Abuse Drug

January 16, 2019
No Increased Adverse Event Risk With Opioid, Alcohol Abuse Drug

Healthcare professionals should feel confident in continuing to prescribe naltrexone for opioid and alcohol addiction as the drug doesn’t cause more adverse events compared to a placebo.

Researchers examined 89 randomized, controlled trials that enrolled nearly 11,200 people and involved oral naltrexone; studies involving opioid or ex-opioid users were excluded. Continue Reading →

Antiepileptic Drug Linked to ADHD in Offspring

January 15, 2019
Antiepileptic Drug Linked to ADHD in Offspring

Taking a commonly used antiepileptic drug while pregnant may increase the risk of attention deficit/hyperactivity disorder (ADHD) in offspring.

Danish researchers conducted an observational study of 913,000 children. The study looked at prenatal exposure to Depakote/Depakene (valproate), as well as other antiepileptic drugs. A total of 580 children were determined Continue Reading →

Pharma Spending on Drug Ads to Consumers Quadruples Over 20 Years

January 14, 2019
Pharma Spending on Drug Ads to Consumers Quadruples Over 20 Years

In 1997, drugmakers spent $1.3 billion on direct-to-consumer drug ads. By 2016, that figure reached $6 billion.

Quick Hits: Nasal Spray Flu Vaccine Comes Up Short; Transdermal HRT Found Safer than Pills

January 10, 2019
Quick Hits: Medication Recommended for Women at High Breast Cancer Risk, FDA Committee Supports Gout Drug & More

The nasal spray vaccine FluMist has proven to be considerably less effective than shots, according to research published in the journal Pediatrics this week. Researchers based their findings on data collected from 17,000 children ages 2 to 17, and results were consistent with research published outside the US. Because the Continue Reading →

Supreme Court Hears Arguments on Fosamax, MedShadow Foundation Contributes Amicus Brief

January 9, 2019

The pharmaceutical company Merck is accused of withholding notification of a serious adverse side effect of Fosamax (and all bisphosphonates), meds used for osteoporosis, from doctors and the public. On Monday the Supreme Court heard arguments from Merck and class action attorneys (the original lead plaintiff is Doris Albrecht) to Continue Reading →

How High? Researchers Test Smoking Pot vs. Vaping to Find Out

January 8, 2019

With the increased legalization of marijuana for both medical and recreational use, there are more ways to experience the effects of marijuana than smoking it. Vaporizers for cannabis oil have become increasingly popular due to the decreased amounts of toxic particles in comparison to combustible smoking.

A small study approved Continue Reading →

Can Aligning Radiotherapy for Breast Cancer with Circadian Rhythms Minimize Side Effects?

January 7, 2019

Radiation, or radiotherapy, for breast cancer patients is one of the most common forms of treatment, and comes with some uncomfortable and harmful side effects. A recent study from the University of Leicester in England has demonstrated that side effects can be minimized by changing the time of day that Continue Reading →

Quick Hits: Voluntary Recall of Some Valsartan Lots, Cryotherapy Risks, France Recalls Breast Implants

January 4, 2019
Quick Hits: Medication Recommended for Women at High Breast Cancer Risk, FDA Committee Supports Gout Drug & More

Quick Hits: Voluntary Recall of Some Valsartan Lots, Cryotherapy Risks, France Recalls Breast Implants

Antidepressants May Increase Hip Fracture Risk in Older Adults

January 2, 2019
Seniors on Many Meds More Likely to Have Falls

Older people who start on antidepressant medications are more than twice as likely to experience a hip fracture compared to peers who don’t use the drugs.

Researchers in Sweden looked at a registry of 408,000 patients aged 65 and older, with an average age of 80. Half were prescribed an Continue Reading →

Most Medications Don’t Help Knee Osteoarthritis Pain Long Term

December 31, 2018
Most Medications Don’t Help Knee Osteoarthritis Pain Long Term

Meta-analysis found that only the supplement glucosamine provided a small improvement in pain and significant improvement in physical functioning.

Quick Hits: Opioids Not That Effective For Chronic Pain, and Many Women Shun Drug For Breast Cancer Prevention

December 20, 2018
Quick Hits: Medication Recommended for Women at High Breast Cancer Risk, FDA Committee Supports Gout Drug & More

Analysis finds opioids not much better than placebo for chronic pain, but with more risks and many women at risk for breast cancer don’t take tamoxifen.